AAVantgarde Bio

Delivering the next generation gene therapies

General Information
Company Name
AAVantgarde Bio
Founded Year
2021
Location (Offices)
Founders / Decision Makers
Number of Employees
38
Industries
Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A
Social Media

AAVantgarde Bio - Company Profile

AAVantgarde is a clinical-stage, international biotechnology company (headquartered in Italy) that has developed two proprietary adeno-associated viral (AAV) vector platforms to address the DNA cargo capacity limitations of AAV vectors

Funding Rounds & Investors of AAVantgarde Bio (0)

View All

There is no investment information

Latest News of AAVantgarde Bio

View All

No recent news or press coverage available for AAVantgarde Bio.

Similar Companies to AAVantgarde Bio

View All
Academie des Arts de Vivre (AAV) - Similar company to AAVantgarde Bio
Academie des Arts de Vivre (AAV) AAV is a travel agency based in Paris and specialised in tailor-made luxury and cultural vacations to France.
Avirmax, Inc. - Similar company to AAVantgarde Bio
Avirmax, Inc. Developing rAAV mediated gene therapy Safe, Effective, Affordable and Accessible
Virovek, Inc. - Similar company to AAVantgarde Bio
Virovek, Inc. Adeno-Associated Virus | 1E+17vg/ml ultra high titer | www.virovek.com
TAAV Biomanufacturing Solutions - Similar company to AAVantgarde Bio
TAAV Biomanufacturing Solutions TAAV is offering neDNA™: an enzymatic, linear, double stranded DNA as the new standard for AAV production.